aristolochic acid i has been researched along with bortezomib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiga, M; Isobe, K; Mandai, S; Mori, T; Nomura, N; Rai, T; Sohara, E; Uchida, S; Yui, N; Zeniya, M | 1 |
1 other study(ies) available for aristolochic acid i and bortezomib
| Article | Year |
|---|---|
The proteasome inhibitor bortezomib attenuates renal fibrosis in mice via the suppression of TGF-β1.
Topics: Animals; Aristolochic Acids; Bortezomib; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Mice; Signal Transduction; Transforming Growth Factor beta1 | 2017 |